Daniele Pastori

Pubblicazioni

Titolo Pubblicato in Anno
Minimizing drug-drug interactions between dabigatran and levetiracetam through clinical management: a case report EUROPEAN HEART JOURNAL. CASE REPORTS 2023
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2023
A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists JOURNAL OF CLINICAL MEDICINE 2023
Relationship between non-invasively detected liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome undergoing PCI CLINICAL RESEARCH IN CARDIOLOGY 2023
Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
An international multidisciplinary consensus statement on MAFLD and the risk of CVD HEPATOLOGY INTERNATIONAL 2023
Prediction of new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention using the C2HEST and mC2HEST scores: A report from the multicenter REALE-ACS registry INTERNATIONAL JOURNAL OF CARDIOLOGY 2023
How to treat patients with splanchnic vein thrombosis: recent advances POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ 2023
C-reactive protein levels are associated with early cardiac complications or death in patients with acute ischemic stroke: a propensity-matched analysis of a global federated health from the TriNetX network INTERNAL AND EMERGENCY MEDICINE 2023
Poststroke Cardiovascular Management: Current Concepts, Integrated Care, and Future Developments CURRENT PROBLEMS IN CARDIOLOGY 2023
Association of proprotein convertase subtilisin/kexin type 9 (PCSK9) levels with abnormally high ankle-brachial index in atrial fibrillation KARDIOLOGIA POLSKA 2023
Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation FRONTIERS IN PHARMACOLOGY 2023
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2023
Aging and Antithrombotic Treatment ANTIOXIDANTS & REDOX SIGNALING 2023
Renin‐angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry EUROPEAN JOURNAL OF INTERNAL MEDICINE 2023
Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS study THROMBOSIS RESEARCH 2023
Risk of venous thromboembolism in autoimmune diseases: A comprehensive review AUTOIMMUNITY REVIEWS 2023
Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2023
Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2023

ERC

  • LS4
  • LS4_10
  • LS7
  • LS7_10

Keywords

cardiovascular disease
anticoagulation
Novel oral anticoagulants
atrial fibrillation
atherosclerosis
NAFLD
NASH
antiphospholipid antibody syndrome
ischemic heart disease
cardiovascular risk
Thrombosis
Atherothrombosis

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma